Cholestasis of pregnancy: A review of the evidence

Journal of Perinatal and Neonatal Nursing

Volumn 19, Issue 3, 2005, Pages 217-225

  Nichols, Amy A ^a  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Cholestasis; Fetal compromise; Jaundice; Pregnancy

Indexed keywords

EID: 24644520840     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200507000-00007     Document Type: Review

References (31)

1. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol. 1997;12:211-216.
2. Davidson K. Intrahepatic cholestasis of pregnancy. Sem Perinatol. 1998;22:104-111.
3. Riely CA. Intrahepatic cholestasis of pregnancy. Clin Liver Dis. 2004;8.
4. Mullally B, Hansen W. Intrahepatic cholestasis of pregnancy: review of the literature. Obestet Gynecol Surv. 2002;57:47-52.
5. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med. 1996;335:569-576.
6. Palmer DG, Eads J. Intrahepatic cholestasis of pregnancy: a critical review. J Perinat Neonat Nurs. 2000;14:39-51.
7. Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med. 2000;32:94-106.
8. Carstens M, Gomez R, Galleguillos G, Medina L, Gonzalez R, Rojas I. Cholestasis of pregnancy managed expectantly is not associated with adverse fetal outcome: a comparative study of 89,135 patients. Am J Obestet Gynecol. 2001;184.
9. Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol. 1999;94:189-193.
10. Berg B, Baez ME, Gonzales MC, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies, and in health individuals, in Chile. J Hepatol. 2000;32:542-546.
11. Davies MH, Ngong JM, Yucesoy M, Acharya SK, Mills CO, Weaver JB. The adverse influence of pregnancy upon sulphation: a clue to the pathogenesis of intrahepatic cholestasis of pregnancy? J Hepatol. 1994;21:1127-1134.
12. Bergasa VB, Jones EA. The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids. Gastroenterology. 1995;108:1582-1588.
13. Bergasa VB, Alling DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. Ann Intern Med. 1995;123:161-167.
14. Germain AM, Kato S, Carvajal JA, Valenzuela GJ, Valdes G, Glasinovic JC. Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol. 2003;189:2.
15. Rodrigues CMP, Marin JJG, Brites D. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and are not altered by ursodeoxycholic acid treatment. Gut. 1999;45:446-452.
16. Redfearn J, Chambers J. Itching in pregnancy? Midwives must be alert. Midwives. 1996;109:36-37.
17. Palma J, Reyes H, Ribalta J, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol. 1997;27:1022-1028.
18. Davies MH, da Silva RCMA, Jones SR, et al. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut. 1995;37:580-584.
19. Rioseco AJ, Ivankovic MB, Manzur A, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol. 1994;170:890-895.
20. Burrows RF, Clavisi O, Burrows E. Interventions for treating cholestasis in pregnancy. Cocbrane Libr. 2004;1.
21. Sadler LC, Lane M, North R. Severe fetal intracranial hemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy. Br J Obestet Gynaecol. 1995;102:169-170.
22. Yankowitz J, Niebyl J. Drug Therapy in Pregnancy 2001. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; chap 8.
23. Paus TC, Schneider G, Van de Vondol, et al. Diagnosis and therapy of intrahepatic cholestasis of pregnancy. A Gastroenterol. 2004;42(7):623-628.
24. Meng L-P, Reyes H, Palma J, Hernandez I, Ribalta J, Sjoval J. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J Hepatol. 1997;27:1029-1040.
25. Wolf J. Liver disease in pregnancy. Med Clin North Am. 1996;80:1167-1187.
26. Brites D, Rodrigues CMP. Elevated levels of bile acids in colostrums of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy. J Hepatol. 1998;29:743-751.
27. Floreani A, Davis P, Grella V, Sacco S, Gangemi M, Chiaramonte M. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol. 1994;101:64-65.
28. Fagan EA. Intrahepatic cholestasis of pregnancy. BMJ. 1994.
29. Lammert F, Marchall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol. 2000;33:1012-1021.
30. Savander M, Ropponen A, Avela K, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut. 2003;52:1025-1029.
31. Incerpi M, Hethamuni R, Goodwin M. Serum bile acids as an indicator of intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2001;184:S189.